Skip to Main Content

News Center

UMB Students Roll Up Sleeves, Administer Vaccines

January 19, 2021

Pharmacy, nursing students volunteer at COVID-19 vaccination clinic.

Ninth Annual M-CERSI Regulatory Science Competition Goes Virtual

January 19, 2021

Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.

SOP Alum to Address Double Pandemics in MLK Celebration Speech

January 13, 2021

Anthony Wutoh, provost and chief academic officer at Howard University, says we must work together for our collective future and the good of society.

Ninth Annual M-CERSI Regulatory Science Competition Goes Virtual

January 19, 2021

Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.

UMB Students Roll Up Sleeves, Administer Vaccines

January 19, 2021

Pharmacy, nursing students volunteer at COVID-19 vaccination clinic.

SOP Alum to Address Double Pandemics in MLK Celebration Speech

January 13, 2021

Anthony Wutoh, provost and chief academic officer at Howard University, says we must work together for our collective future and the good of society.

Study Examines Projected Health and Economic Burden of COPD in the U.S.

December 18, 2020

Research led by Dr. Zafar Zafari will help inform future studies and guide policy decisions to reduce health care and economic costs associated with COPD in the U.S.

The PATIENTS Program Kicks-Off New Fundraising Campaign with Virtual Event

November 25, 2020

Key stakeholders from The PATIENTS Program come together to celebrate past achievements and look towards future successes.

SOP’s Qato Selected for National Leadership Program

November 24, 2020

The Robert Wood Johnson Foundation’s Culture of Health Leaders program will provide Dr. Danya Qato with the tools to support her development as an agent of change for health equity and structural transformation.

UMSOP and KamTek Collaborate on Therapeutic Development to Treat Deadly Infections

November 23, 2020

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.